| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 73 |
| 1 | ASPIRIN | 28 |
| 2 | ASPIRIN 325 MG | 28 |
| 3 | ASPIRIN 81 MG | 28 |
| 4 | OMEPRAZOLE MAGNESIUM | 23 |
| 5 | CELECOXIB | 21 |
| 6 | LEVOTHYROXINE SODIUM | 21 |
| 7 | PANTOPRAZOLE | 19 |
| 8 | RAMIPRIL | 19 |
| 9 | DICLOFENAC SODIUM | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 2 | 0.0045 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 12 | 0.0043 |
| 2 | TRIMIPRAMINE | 4 | 0.0036 |
| 3 | CLOMIPRAMINE HYDROCHLORIDE | 13 | 0.0028 |
| 4 | CALCIUM ANTACID | 1 | 0.0023 |
| 5 | DOXEPIN HYDROCHLORIDE | 16 | 0.0013 |
| 6 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 7 | CEFUROXIME SODIUM | 1 | 0.0008 |
| 8 | ALENDRONATE SODIUM | 73 | 0.0007 |
| 9 | ACETYLCYSTEINE | 6 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 47 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 28 |
| 2 | Corticosteroid [EPC] | 23 |
| 3 | Benzodiazepine [EPC] | 22 |
| 4 | Proton Pump Inhibitor [EPC] | 20 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 19 |
| 6 | Vitamin D [EPC] | 19 |
| 7 | Vitamin C [EPC] | 18 |
| 8 | Estrogen [EPC] | 14 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 4 | 0.0004 |
| 1 | Calcitonin [EPC] | 1 | 0.0003 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 3 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Calcitonin Gene-related Peptide Antagonist [EPC] | 2 | 0.0002 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 19 | 0.0001 |
| 7 | Nonergot Dopamine Agonist [EPC] | 2 | 0.0001 |
| 8 | Antidote [EPC] | 8 | 0.0001 |
| 9 | Aluminum Complex [EPC] | 3 | 0.0001 |